Drug Type Gene editing |
Synonyms- |
Target |
Action modulators |
Mechanism BCL11A modulators(B-cell lymphoma/leukemia 11A modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia, Sickle Cell | Preclinical | United States | 03 Aug 2024 |